Login / Signup

Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.

Sanjeeb BhandariDavid SquirrellVuong NguyenNancy WangJane M WellsTerence TanRachel BarnesRichard BarryDaniel BarthelmesMark Gillies
Published in: Eye (London, England) (2021)
Bevacizumab is an effective treatment for DMO in unselected populations.
Keyphrases
  • optical coherence tomography
  • diabetic retinopathy
  • type diabetes
  • combination therapy
  • replacement therapy
  • smoking cessation